Ever Supreme Bio Technology Balance Sheet Health
Financial Health criteria checks 6/6
Ever Supreme Bio Technology has a total shareholder equity of NT$1.8B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$2.1B and NT$233.0M respectively. Ever Supreme Bio Technology's EBIT is NT$337.7M making its interest coverage ratio -24.2. It has cash and short-term investments of NT$1.3B.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -24.2x |
| Cash | NT$1.34b |
| Equity | NT$1.84b |
| Total liabilities | NT$232.96m |
| Total assets | NT$2.08b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6712's short term assets (NT$1.5B) exceed its short term liabilities (NT$231.6M).
Long Term Liabilities: 6712's short term assets (NT$1.5B) exceed its long term liabilities (NT$1.3M).
Debt to Equity History and Analysis
Debt Level: 6712 is debt free.
Reducing Debt: 6712 had no debt 5 years ago.
Debt Coverage: 6712 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6712 has no debt, therefore coverage of interest payments is not a concern.